Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Exercise and Olanzapine-samidorphan [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating exercise in combination with olanzapine-samidorphan for schizophrenia and related disorders, including schizoaffective an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine-samidorphan (olanzapine-samidorphan)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophenia Disorder, Schizoaffective Disorder | Phase 4 | Status: RECRUITING